Soleno Therapeutics (6XC.MU) Q2 2026 Earnings

12MayConfirmed
Q1 2026
Next
0.58
0.61
0.64
0.68

Details

Expected EPS
0.5793124000000001
Actual EPS
N/A
Surprise EPS
-0.58
Surprise Percent
+100%

Description

Soleno Therapeutics (6XC.MU) will report earnings of for Q2 2026 on May 12, 2026.

0 Comments

Share your thoughts